Brenda M. Luken

1.9k total citations
29 papers, 1.4k citations indexed

About

Brenda M. Luken is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Brenda M. Luken has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 18 papers in Hematology and 12 papers in Genetics. Recurrent topics in Brenda M. Luken's work include Complement system in diseases (17 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Brenda M. Luken is often cited by papers focused on Complement system in diseases (17 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Brenda M. Luken collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Brenda M. Luken's co-authors include David A. Lane, James T. B. Crawley, Sacha Zeerleder, Jan Voorberg, Gerben Marsman, Rob Fijnheer, Yaozu Xiang, Rens de Groot, Ellen A.M. Turenhout and Wouter Pos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Science Advances.

In The Last Decade

Brenda M. Luken

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda M. Luken Netherlands 20 925 720 389 230 213 29 1.4k
Katalin Váradi Austria 21 376 0.4× 1.5k 2.1× 556 1.4× 101 0.4× 107 0.5× 55 1.8k
Debjit Biswas United States 8 414 0.4× 220 0.3× 132 0.3× 189 0.8× 179 0.8× 12 777
Katrin Moser Germany 14 923 1.0× 267 0.4× 146 0.4× 81 0.4× 363 1.7× 15 1.6k
Evangelos Eleutherakis‐Papaiakovou Greece 24 155 0.2× 965 1.3× 288 0.7× 126 0.5× 888 4.2× 154 1.7k
Lene Meldgaard Knudsen Denmark 23 430 0.5× 1.1k 1.6× 200 0.5× 59 0.3× 989 4.6× 50 1.9k
Tor Henrik Anderson Tvedt Norway 18 314 0.3× 632 0.9× 153 0.4× 36 0.2× 176 0.8× 66 1.0k
Mojtaba Akhtari United States 19 263 0.3× 444 0.6× 190 0.5× 24 0.1× 290 1.4× 77 1.2k
Fumio Bessho Japan 29 230 0.2× 1.1k 1.6× 286 0.7× 172 0.7× 863 4.1× 102 2.4k
S Kariyone Japan 13 300 0.3× 672 0.9× 243 0.6× 35 0.2× 177 0.8× 62 1.1k
Julian R. Pratt United Kingdom 16 894 1.0× 142 0.2× 96 0.2× 327 1.4× 209 1.0× 23 1.5k

Countries citing papers authored by Brenda M. Luken

Since Specialization
Citations

This map shows the geographic impact of Brenda M. Luken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda M. Luken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda M. Luken more than expected).

Fields of papers citing papers by Brenda M. Luken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda M. Luken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda M. Luken. The network helps show where Brenda M. Luken may publish in the future.

Co-authorship network of co-authors of Brenda M. Luken

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda M. Luken. A scholar is included among the top collaborators of Brenda M. Luken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda M. Luken. Brenda M. Luken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avondt, Kristof Van, Ingrid Bulder, Gerard van Mierlo, et al.. (2023). Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps. Transfusion Medicine and Hemotherapy. 50(4). 321–329. 4 indexed citations
2.
Luken, Brenda M., Bérangère S. Joly, Karen Vanhoorelbeke, et al.. (2023). Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 21(12). 3402–3413.
3.
Golen, Rowan F. van, Megan J. Reiniers, Gerben Marsman, et al.. (2019). The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1192–1200. 26 indexed citations
4.
Birocchi, Simone, René van Oerle, Sacha Zeerleder, et al.. (2019). Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease. Frontiers in Cardiovascular Medicine. 6. 33–33. 12 indexed citations
5.
Luken, Brenda M., Erfan Nur, Sacha Zeerleder, et al.. (2017). Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state. Journal of Thrombosis and Haemostasis. 15(7). 1392–1402. 24 indexed citations
6.
Stroo, Ingrid, Sacha Zeerleder, Chao Ding, et al.. (2017). Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation. Thrombosis and Haemostasis. 117(8). 1601–1614. 37 indexed citations
7.
Marsman, Gerben, Sacha Zeerleder, & Brenda M. Luken. (2016). Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation. Cell Death and Disease. 7(12). e2518–e2518. 175 indexed citations
8.
Avondt, Kristof Van, Ingrid Bulder, Robin van Bruggen, et al.. (2016). Free Iron in Sera of Patients with Sickle Cell Disease Contributes to the Release of Neutrophil Extracellular Traps. Blood. 128(22). 161–161. 8 indexed citations
9.
Marsman, Gerben, Femke Stephan, Karina de Leeuw, et al.. (2015). FSAP‐mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE. European Journal of Immunology. 46(3). 762–771. 10 indexed citations
10.
Crawley, James T. B., Rens de Groot, Yaozu Xiang, Brenda M. Luken, & David A. Lane. (2011). Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 118(12). 3212–3221. 214 indexed citations
11.
George, JN, Sara K. Vesely, Deirdra R. Terrell, et al.. (2011). Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 97(2). 297–303. 55 indexed citations
12.
Pos, Wouter, Brenda M. Luken, Nicoletta Sorvillo, Johanna A. Kremer Hovinga, & Jan Voorberg. (2011). Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 9(7). 1285–1291. 31 indexed citations
13.
Luken, Brenda M., et al.. (2010). The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function. Blood. 115(23). 4910–4913. 37 indexed citations
14.
Andersson, Helena, James T. B. Crawley, Brenda M. Luken, et al.. (2010). Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood. 115(23). 4878–4885. 31 indexed citations
15.
Luken, Brenda M.. (2008). Extracellular control of VWF multimer size and thiol‐disulfide exchange. Journal of Thrombosis and Haemostasis. 6(7). 1131–1134. 2 indexed citations
16.
Pos, Wouter, Brenda M. Luken, Johanna A. Kremer Hovinga, et al.. (2008). VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 7(3). 421–428. 45 indexed citations
17.
Riksen, Niels P., Brenda M. Luken, Ina S. Klasen, et al.. (2007). Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship. Haematologica. 92(6). e74–e76. 6 indexed citations
18.
Luken, Brenda M., Paul Kaijen, Ellen A.M. Turenhout, et al.. (2006). Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 4(11). 2355–2364. 58 indexed citations
19.
20.
Luken, Brenda M., Ellen A.M. Turenhout, Paul Kaijen, et al.. (2006). Amino acid regions 572–579 and 657–666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP. Thrombosis and Haemostasis. 96(9). 295–301. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katalin Váradi Breakdown of academic impact, for papers by Debjit Biswas Breakdown of academic impact, for papers by Katrin Moser Breakdown of academic impact, for papers by Evangelos Eleutherakis‐Papaiakovou Breakdown of academic impact, for papers by Lene Meldgaard Knudsen Breakdown of academic impact, for papers by Tor Henrik Anderson Tvedt Breakdown of academic impact, for papers by Mojtaba Akhtari Breakdown of academic impact, for papers by Fumio Bessho Breakdown of academic impact, for papers by S Kariyone Breakdown of academic impact, for papers by Julian R. Pratt
Rankless by CCL
2026